Question to the Department of Health and Social Care:

To ask Her Majesty's Government whether they will place in the Library of the House copies of estimates made by the Joint Committee on Immunisation and Vaccination of the number of cases of invasive pneumococcal disease that may result from a reduction in the number of doses in the infant pneumococcal vaccination programme.

Public Health England has undertaken modelling on the impact of a reduced dose pneumococcal conjugate vaccine (PCV) schedule in the United Kingdom. The Joint Committee on Vaccination and Immunisation (JCVI) reviewed the modelling in October 2017 and after considering all relevant evidence advised a revised schedule for PCV13 vaccine, with vaccination offered at three months and 12 months.

The JCVI is currently undertaking a consultation on their advice, therefore the estimates requested are not yet finalised. The modelling will be submitted for publication in a peer reviewed journal in spring 2018.